TY  - GEN
AU  - Hayashi,Norio
AU  - Izumi,Namiki
AU  - Kumada,Hiromitsu
AU  - Okanoue,Takeshi
AU  - Tsubouchi,Hirohito
AU  - Yatsuhashi,Hiroshi
AU  - Kato,Mai
AU  - Ki,Rito
AU  - Komada,Yuji
AU  - Seto,Chiharu
AU  - Goto,Shoichiro
TI  - Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial
SN  - 1600-0641
PY  - 2015///0811
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepatitis C
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Interferon-alpha
KW  - Interferons
KW  - Interleukins
KW  - Male
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - RNA, Viral
KW  - analysis
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Simeprevir
KW  - Sulfonamides
KW  - Treatment Failure
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jhep.2014.04.004
ER  -